Özdirik, B., Stueven, A., Knorr, J., Geisler, L., Mohr, R., Demir, M., . . . Roderburg, C. (2020). Soluble Urokinase Plasminogen Activator Receptor (suPAR) Concentrations Are Elevated in Patients with Neuroendocrine Malignancies. J Clin Med.
Citação norma ChicagoÖzdirik, Burcin, et al. "Soluble Urokinase Plasminogen Activator Receptor (suPAR) Concentrations Are Elevated in Patients With Neuroendocrine Malignancies." J Clin Med 2020.
ציטוט MLAÖzdirik, Burcin, et al. "Soluble Urokinase Plasminogen Activator Receptor (suPAR) Concentrations Are Elevated in Patients With Neuroendocrine Malignancies." J Clin Med 2020.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.